Active Pharmaceutical IngredientFeaturedIP / EP / USP

Semaglutide

Description

A GLP-1 receptor agonist that regulates blood sugar and suppresses appetite by mimicking a naturally occurring gut hormone. Delivers sustained glycemic control and significant weight reduction with once-weekly dosing.

Applications

Formulated into subcutaneous injectable pens and oral tablets for type 2 diabetes and chronic weight management.

Specifications

Therapeutic ClassDiabetes & Metabolic Health
AppearanceWhite To Off-White Lyophilized Powder
Assay / Purity≥98%
SolubilitySoluble In Water
GradeIP / USP / EP
Manufacturing ComplianceWHO-GMP / EU-GMP / USFDA

Get a tailored quotation for Semaglutide within 24 business hours.

Request QuoteWhatsApp Enquiry

Response within 24 business hours